Contact information
laurent.servais@paediatrics.ox.ac.uk
Dom Tromans
dom.tromans@paediatrics.ox.ac.uk
Laurent Servais
Professor of Paediatric Neuromuscular Diseases, Academic Director of the new Paediatric CRF
Biosketch
I am Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre and Invited Professor of Child Neurology at Liège University.
After graduating from Louvain Medical School, Brussels, Belgium in 1999, I completed a PhD in Neuroscience (cerebellar electrophysiology in alert living mice) from Free University of Brussels, Belgium, followed by residencies in child neurology at the Free University of Brussels and Robert Debré Hospital, Paris. In 2008, I took a position in neuromuscular disease and clinical research at the Institute of Myology in Paris, where my interest and expertise in neuromuscular diseases flourished. I was subsequently appointed Head of Clinical Trials and Database Services. Most recently, I served as Head of the Institute of Myology’s I-Motion (Institute Of Muscle-Oriented Translational Innovation), and Head of the Neuromuscular Centre in Liège, Belgium. I have joined MD UK Oxford Neuromuscular Center and the University of Oxford in September 2019.
I have been involved as principal investigator in numerous clinical trials to test treatments for Duchenne muscular dystrophy and spinal muscular atrophy (SMA).
I am the leader of the newborn screening program for SMA in southern Belgium where we are conducting a medico-economic analysis of newborn screening. My main research expertise covers the development of innovative outcome measures, including connected devices for real-life patients’ evaluation.
Recent publications
-
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA).
Journal article
Oskoui M. et al, (2023), J Neurol
-
Good News Never Hurts.
Journal article
Ramdas S. and Servais L., (2023), Eur J Paediatr Neurol
-
Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy.
Journal article
Ngawa M. et al, (2023), Therapeutic advances in neurological disorders, 16
-
Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect
Journal article
Vincent-Genod D. et al, (2023), Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association, 35, 36 - 41
-
Early clinical and pre-clinical therapy development in Nemaline Myopathy.
Journal article
Fisher G. et al, (2022), Expert Opin Ther Targets